HEPATITIS PREVALENCE IN POPULATION OF KALLAR KAHAR, PUNJAB, PAKISTAN: A CROSS-SECTIONAL STUDY

Authors

  • Anam Khan Fauji Foundation Hospital, Rawalpindi, Pakistan. Author
  • Shanza Akbar Riphah International University (Gulberg Green Campus), Islamabad, Pakistan. Author https://orcid.org/0009-0006-2901-9436
  • Saqib Hussain THQ Hospital, Kalar Kahar, Chakwal, Pakistan. Author

DOI:

https://doi.org/10.71000/1ek62393

Keywords:

Cross-Sectional Studies, Hepatitis B, Hepatitis C, Pakistan, Polymerase Chain Reaction, Prevalence, Risk Factors

Abstract

Background: Hepatitis B virus (HBV) and hepatitis C virus (HCV) are major global health threats, particularly in endemic countries such as Pakistan. These viruses are responsible for chronic liver disease, cirrhosis, and hepatocellular carcinoma, placing a significant burden on the healthcare system. Despite the availability of effective antiviral therapies and preventive strategies, the prevalence of HBV and HCV remains high. Understanding the local epidemiology, risk factors, and distribution patterns is essential to strengthen public health interventions and align with elimination targets.

Objective: The study aimed to determine the frequency of HBV and HCV infections in the local population of Kallar Kahar, identify demographic trends, assess associated risk factors, and provide evidence-based recommendations for prevention and control.

Methods: A cross-sectional study was conducted over six months, from January 2021 to July 2021, at the Hepatitis Clinic of THQ Hospital, Kallar Kahar. A total of 2000 individuals were recruited through randomized sampling. Inclusion criteria required availability of CNIC/Form-B, absence of prior hepatitis screening or treatment, and verbal informed consent. Screening was performed using an immunochromatographic test for anti-HCV and an ELISA kit for HBsAg. All positive samples were further confirmed through polymerase chain reaction (PCR). Data on demographics, vaccination status, and potential risk exposures were collected using structured interviews. Statistical analysis was carried out using SPSS software.

Results: Out of 2000 participants, 68% (n=1360) were females and 31% (n=640) were males, while 71.9% (n=1437) fell in the 15–49 years age group. Screening identified 3.4% (n=67) as positive and 96.7% (n=1933) as negative. Among the 67 positives, PCR confirmed 26.9% (n=18) as HCV positive and 20.9% (n=14) as HBV positive, while 7.5% (n=5) samples were rejected.

Conclusion: The study confirms that HBV and HCV infections are endemic in Pakistan, with a higher prevalence of HCV compared to HBV in this population. These findings highlight the urgent need for improved awareness, routine screening, vaccination programs, and stricter infection control practices. Community engagement and policy-level interventions are essential to reduce the burden and prevent further transmission.

Author Biographies

  • Anam Khan, Fauji Foundation Hospital, Rawalpindi, Pakistan.

    Postgraduate Trainee, Fauji Foundation Hospital, Rawalpindi, Pakistan.

  • Shanza Akbar, Riphah International University (Gulberg Green Campus), Islamabad, Pakistan.

    Research Scholar, Department of Clinical Psychology, Riphah International University (Gulberg Green Campus), Islamabad, Pakistan.

  • Saqib Hussain, THQ Hospital, Kalar Kahar, Chakwal, Pakistan.

    Medical Superintendent, THQ Hospital, Kalar Kahar, Chakwal, Pakistan.

References

Alberts CJ, Clifford GM, Georges D, Negro F, Lesi OA, Hutin YJ, et al. Worldwide prevalence of hepatitis B virus and hepatitis C virus among patients with cirrhosis at country, region, and global levels: a systematic review. Lancet Gastroenterol Hepatol. 2022;7(8):724-35.

Ahmed S, Ayub M, Naeem M, Nazir FH, Hussain A, Ghilzai D, et al. Thalassemia Patients from Baluchistan in Pakistan Are Infected with Multiple Hepatitis B or C Virus Strains. Am J Trop Med Hyg. 2021;104(4):1569-76.

Israr M, Ali F, Nawaz A, Idrees M, Khattak A, Ur Rehman S, et al. Seroepidemiology and associated risk factors of hepatitis B and C virus infections among pregnant women attending maternity wards at two hospitals in Swabi, Khyber Pakhtunkhwa, Pakistan. PLoS One. 2021;16(8):e0255189.

Wu S, Wang J, Guo Q, Lan H, Sun Y, Ren M, et al. Prevalence of human immunodeficiency virus, syphilis, and hepatitis B and C virus infections in pregnant women: a systematic review and meta-analysis. Clin Microbiol Infect. 2023;29(8):1000-7.

Vincent JP, Nyamasege C, Wang S, Madec Y, Shimakawa Y. Prevalence of hepatitis B, C, and D virus infection in Haiti: A systematic review and meta-analysis. Front Public Health. 2022;10:1099571.

Miyano S, Pathammavong C, Ichimura Y, Sugiyama M, Phounphenghack K, Tengbriacheu C, et al. Prevalence of hepatitis B and C virus infections in Lao People's Democratic Republic: The first national population-based cross-sectional survey. PLoS One. 2022;17(12):e0278933.

Jørgensen A, Bjørn-Mortensen K, Graff Jensen S, Sloth Andersen E, Ravn P. Prevalence of hepatitis B and C at a major tuberculosis centre in Denmark. Infect Dis (Lond). 2021;53(3):196-200.

Bitty-Anderson AM, Ferré V, Gbeasor-Komlanvi FA, Tchankoni MK, Sadio A, Salou M, et al. Prevalence of hepatitis B and C among female sex workers in Togo, West Africa. PLoS One. 2021;16(12):e0259891.

Shah H, Ur Rahman Z, Khan M, Zaman F, Badshah S. The Prevalence of Blood Borne Diseases in Blood Donors of Peshawar, Khyber Pakhtunkhwa, Pakistan. Recent Adv Antiinfect Drug Discov. 2023;18(3):215-20.

Raziq K, Shah SQA, Tariq M, Badshah S, Riaz U, Ibáñez-Arancibia E, et al. Prevalence and risk factors of hepatitis B and C in Bahawalpur: a hospital-based study. Braz J Biol. 2025;85:e288357.

Samo AA, Laghari ZA, Baig NM, Khoso GM. Prevalence and Risk Factors Associated with Hepatitis B and C in Nawabshah, Sindh, Pakistan. Am J Trop Med Hyg. 2020;104(3):1101-5.

Muhammad SK, Shaikh BA, Gurbakshani KM, Jalbani AU. Frequency triple hepatitis (hepatitis B and C and D virus) in HBs Ag positive patients. Rawal Medical Journal. 1970 Jan 1;37(2):142-.

Chang CH, Liu CY, Chen SJ, Tsai HC. Hepatitis C virus and hepatitis B virus in patients with schizophrenia. Medicine (Baltimore). 2021;100(22):e26218.

Souza-Silva G, Mol MPG. Hepatitis B or C prevalence in waste pickers from South America: a systematic review. J Public Health (Oxf). 2021;43(4):e578-e83.

Chikwendu A, Unikutelle HL, Olumide AT. Hepatitis B and C virus prevalence among patients and healthcare workers' prevention practices towards the viruses in a secondary healthcare facility in Northern Nigeria. Pan Afr Med J. 2023;46:82.

Lo Presti A, Ceccarelli F, Dorrucci M, Farchi F, Pirone C, Garufi C, et al. Hepatitis B and C virus infection in patients with Systemic and Cutaneous Lupus Erythematosus. New Microbiol. 2022;45(4):296-303.

Not A, Ouaarab-Essadek H, Montoro M, Treviño B, Buti M, Morillas RM, et al. Hepatitis B and C Screening and Linkage to Care in Migrants From Endemic Countries in Barcelona Through a Community Action. Liver Int. 2025;45(6):e70126.

Badshah Y, Shabbir M, Khan K, Zafar S, Afsar T, Husain FM, et al. HCV and HBV genotypes: vital in the progression of HCV/ HBV co-infection. BMC Gastroenterol. 2025;25(1):6.

Jamal S, Mansoor N, Ali A, Nadeem A, Aijaz J, Meraj F. Degree of blood safety of voluntary non-remunerated versus replacement blood donations: A multi-centre study of the large cohort of blood donors from two provinces of Pakistan. Vox Sang. 2023;118(12):1078-85.

Asghar MS, Rasheed U, Hassan M, Akram M, Yaseen R, Fayaz B. A CROSS-SECTIONAL SCREENING SURVEY ON THE SEROPREVALENCE OF HEPATITIS B AND HEPATITIS C AMONGST THE GENERAL POPULATION OF RURAL DISTRICTS OF SINDH, PAKISTAN. Arq Gastroenterol. 2021;58(2):150-6.

Alamneh TS, Walker JG, Lim AG, Alam E, Hamid S, Foster GR, et al. Changes in the prevalence of hepatitis B and C viral infections in Sindh province, Pakistan: Findings from two sero-surveys in 2007 and 2019. J Viral Hepat. 2024;31(11):645-56.

Kaewdech A, Charatcharoenwitthaya P, Piratvisuth T. Asian Perspective on Hepatitis B Virus and Hepatitis C Virus Elimination. Viruses. 2024;17(1).

Downloads

Published

2025-09-28